Latest filing published 27 May 2020 for Y-mAbs Therapeutics, Inc., €1.8M.
Filing timeline
BuySaleInsider track record
Mahiuddin Ahmed: trading record in brief
Mahiuddin Ahmed appears in our data through filings on Y-mAbs Therapeutics, Inc. shares, published by SEC (Form 4). Between 12 May 2020 and 26 May 2020, the trades on record add up to 5 filings.
Sales make up the whole of the open-market record (5 sales, €3.9M).
Most recently, on 27 May 2020, the filings show an open-market sale worth €1.8M in Y-mAbs Therapeutics, Inc. Typically, a trade is published a median of 1 day after it takes place. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Mahiuddin Ahmed
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 50,000 shares@ US$39.3845.4% of flowCommon StockSEC:0001104659-20-066408:0
- 19,492 shares@ US$39.4917.9% of flowCommon StockSEC:0001104659-20-064258:0
- 10,000 shares@ US$39.249.1% of flowCommon StockSEC:0001104659-20-064258:1
- 10,508 shares@ US$37.649.3% of flowCommon StockSEC:0001104659-20-062619:0
- 20,000 shares@ US$39.1918.3% of flowCommon StockSEC:0001104659-20-060887:0
5 of 5 declarations